Microcalcification 'fingerprints' can yield info about cancer

byCornell UniversityLeft, a pathology stain of a ductal carcinoma, showing cells and connective tissue. Right, a Raman mapping of the calcification, which was captured by a technique that detect

Updated on: January 08,2024 9

Microcalcification 'fingerprints' can yield info about cancer

byCornell UniversityLeft, a pathology stain of a ductal carcinoma, showing cells and connective tissue. Right, a Raman mapping of the calcification, which was captured by a technique that detect

Updated on:January 08,2024 9

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on: April 06,2024 0

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on:April 06,2024 0

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on: May 20,2024 6

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on:May 20,2024 6

Cancer during young adulthood carries long-term mental toll, study finds

Updated on: June 14,2025 0

Cancer during young adulthood carries long-term mental toll, study finds

Updated on:June 14,2025 0

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on: March 01,2024 12

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on:March 01,2024 12

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on: September 10,2024 0

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on:September 10,2024 0

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on: January 22,2024 12

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on:January 22,2024 12

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Updated on: April 22,2024 11

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Updated on:April 22,2024 11

Cancer survivors who quit smoking found to have 36% lower cardiovascular risk than those who continue

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainCancer patients who continue smoking after their diagnosis have a nearly doubled risk of heart attack, stroke or death due to car

Updated on: January 23,2024 20

Cancer survivors who quit smoking found to have 36% lower cardiovascular risk than those who continue

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainCancer patients who continue smoking after their diagnosis have a nearly doubled risk of heart attack, stroke or death due to car

Updated on:January 23,2024 20

Aggressive breast cancer linked to African ancestry

Updated on: January 02,2024 8

Aggressive breast cancer linked to African ancestry

Updated on:January 02,2024 8

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024 3

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024 3

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on: January 07,2024 10

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on:January 07,2024 10